The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
2721 GENTAMYCIN SULPHATE GENTAMICIN SULPHATE EQ.TO GENTAMICIN BASE 40 MG/ ML (80 MG/2ML) SOLUTION FOR INJECTION VIAL INFECTIONS DUE TO SUSCEPTIBLE ORGANISMS EG-SEPTICAEMIA, RESPIRATORY TRACT INFECTIONS, URINARY TRACT INFECTION NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD T.P DRUG LABORATORIES (1969) CO., LTD THAILAND CERTIFICATE RELEASED 06 I 0818/96 16-JAN-2025 15-JAN-2030 View
2722 GENTA-OPH EYE DROPS GENTAMICIN SULFATE EQ.TO GENTAMICIN 3 MG/ML SOLUTION BOTTLE FOR THE TREATMENT OF INFECTIONS, CAUSED BY SUSCEPTIBLE MICROORGANISM, OF THE EXTERNAL EYE AND ADNEXA, WHICH CAUSED CONJUNCTIVITIS, BLEPHARITIS, DACRYOCYSTITIS, KERATITIS, TRACHOMA NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD SENG THAI COMPANY CO.,LTD THAILAND CERTIFICATE RELEASED 02 I 5701/24 26-FEB-2024 25-FEB-2027 View
2723 DEZOR PLUS SHAMPOO KETOCONAZOLE 2 % W/V, ZINC PYRITHIONE 1 % W/W SHAMPOO BOTTLE FOR USE IN THE TREATMENT OF DANDRUFF AND SEBORRHOEIC DERMATITIS OF SCALP NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD HOE PHARMACEUTICALS SDN. BHD MALAYSIA STEP 1: RECEIVE (RENEW) 11 I 1990/00 08-SEP-2022 07-SEP-2025 View
2724 GLAUCO-OPH EYE DROPS STERILE 0.50 % TIMOLOL MALEATE EQ.TO TIMOLOL 5 MG SOLUTION BOTTLE FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH OCULAR HYPERTENSION, CHRONIC OPEN ANGLE GLAUCOMA, APHAKIA GLAUCOMA, SECONDARY GLAUCOMA NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD SENG THAI COMPANY CO.,LTD THAILAND CERTIFICATE RELEASED 10 I 5616/23 09-Oct-2023 08-Oct-2026 View
2725 GLIMEPIRIDE DENK 2 GLIMEPIRIDE 2 MG TABLET PVC/PVDC-ALU BLISTERPACK TREATMENT OF TYPE 2 DIABETES MELLITUS WHEN DIET, PHYSICAL EXERCISE AND WEIGHT REDUCTION ALONE ARE NOT ADEQUATE. NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD DENK PHARMA GMBH & CO., LTD GERMANY CERTIFICATE RELEASED 11 I 3974/13 25-SEP-2024 24-SEP-2029 View
2726 GLIMEPIRIDE DENK 3 GLIMEPIRIDE 3 MG TABLET PVC/PVDC-ALU BLISTERPACK TREATMENT OF TYPE 2 DIABETES MELLITUS WHEN DIET, PHYSICAL EXERCISE AND WEIGHT REDUCTION ALONE ARE NOT ADEQUATE. NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD DENK PHARMA GMBH & CO., LTD GERMANY CERTIFICATE RELEASED 11 I 3975/13 25-SEP-2024 24-SEP-2029 View
2727 H-CORT CREAM HYDROCORTISONE 1% W/W CREAM Tube SUPPRESSION OF SKIN DISEASES IN WHICH INFLAMMATION IS A PROMINENT FEATURE, E.G. ECZEMA, INFANTILE ECZEMA, ATROPIC DERMATITIS, DERMATITIS HERPETIFORMIS, CONTACT DERMATITIS, NEURODERMATITIS, PSORIASIS AND INTERTRIGO NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD HOE PHARMACEUTICALS SDN. BHD MALAYSIA CERTIFICATE RELEASED 10 I 2134/02 03-Oct-2023 02-Oct-2026 View
2728 H-CORT OINTMENT 1% W/W HYDROCORTISONE BASE 1% W/W OINTMENT Tube SUPPRESSION OF SKIN DISEASES IN WHICH INFLAMMATION IS A PROMINENT FEATURE, E.G.ECZEMA, INFANTILE ECZEMA, ATROPIC DERMATITIS, DERMATITIS HERPETIFORMIS, CONTACT DERMATITIS, NEURODERMATITIS, PSORIASIS AND INTERTRIGO. NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD HOE PHARMACEUTICALS SDN. BHD MALAYSIA CERTIFICATE RELEASED 10 I 2133/02 08-SEP-2022 07-SEP-2025 View
2729 HISTA OPH EYE DROPS EACH 100 ML CONTAINS: ANTAZOLINE HCL 0.05 % W/V, TETRAHYDROZOLINE HCL 0.04 % W/V SOLUTION BOTTLE FOR THE TREATMENT OF ALLERGIC CONJUNCTIVITIS, CONGESTION CAUSED BY HAY-FEVER CONJUNCTIVITIS, DRUG OR CHEMICAL HYPERSENSITIVITY REACTION, EXCESSIVE LACRIMAL SECRETION OR STENOSIS OF THE LACRIMAL CANAL. NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD SENG THAI COMPANY CO.,LTD THAILAND CERTIFICATE RELEASED 10 I 5617/23 09-Oct-2023 08-Oct-2026 View
2730 HOE GENTAMICIN CREAM 0.1 % GENTAMICIN SULPHATE 0.17% W/W CREAM TUBE TREATMENT OF IMPETIGO, ERYTHEMA AND OTHER LOCALISED PRIMARY BACTERIAL SKIN INFECTION WITH A GRAM-NEGATIVE COMPONENT AND ALSO FOR SECONDARY BACTERIAL INFECTIONS COMPLICATING OTHER PRE-EXISTING DERMATOSES NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD HOE PHARMACEUTICALS SDN. BHD MALAYSIA CERTIFICATE RELEASED 07 I 2106/02 30-JAN-2024 29-JAN-2027 View